D-N-Acetylgalactosamine|CS-D0256|1811-31-0

D-N-Acetylgalactosamine

$78.20

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. No lead time available. Please request a quote.
Sku TS246CS-D0256_10_G
ChemScene
Get Bulk Quote

Product Information

Product Name
D-N-Acetylgalactosamine
Brand Name
ChemScene
Product Number
CS-D0256
CAS
1811-31-0
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
35717
IUPAC Name
N-(3R,4R,5R,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-ylacetamide
InChI Key
OVRNDRQMDRJTHS-KEWYIRBNSA-N
SMILES
CC(=O)NC@@H1C@H(C@H(C@H(OC1O)CO)O)O

References

Correction: Hepatic targeting in ASCVD: integrating lipid lowering and inflammation modulation from statins to gene editing
Publication Name: Journal of Translational Medicine
Publication Date: 2026-05-11
DOI: 10.1186/s12967-025-07647-0|10.1186/s12967-026-08192-0

Zilebesiran: an RNA interference agent—its need and potential to transform hypertension treatment
Publication Name: The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology
Publication Date: 2026-03-01
DOI: 10.1186/s43044-026-00724-9

Base editing milestone for familial hypercholesterolemia
Publication Name: Nature Medicine
Publication Date: 2026-03
DOI: 10.1038/s41591-026-04220-0

In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial
Publication Name: Nature Medicine
Publication Date: 2026-03
DOI: 10.1038/s41591-026-04254-4

Choosing the Right Non-Statin Therapy for the Right Patient – How To Sequence Advanced Lipid-Lowering Therapies
Publication Name: Current Atherosclerosis Reports
Publication Date: 2026-02-26
DOI: 10.1007/s11883-026-01390-7